» Articles » PMID: 29541888

Nobiletin-Ameliorated Lipopolysaccharide-Induced Inflammation in Acute Lung Injury by Suppression of NF-κB Pathway In Vivo and Vitro

Overview
Journal Inflammation
Date 2018 Mar 16
PMID 29541888
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Nobiletin (NOB), a citrus polymethoxy flavonoid, has been reported to exhibit anti-inflammatory, anti-cancer, and anti-insulin resistance activities. Although the anti-inflammatory activity of NOB already reported, its involvement in lung protection has not been reported. Thus, this study aimed to investigate the anti-inflammatory response of NOB in lipopolysaccharide (LPS)-stimulated A549 cells and LPS-induced acute lung injury (ALI) in mice. The animals were pre-treated with NOB (5, 10, and 20 mg/kg) or DEX (5 mg/kg) at 12 and 1 h before intranasal instillation of LPS. The severity of pulmonary injury was evaluated 6 h after LPS administration. Results suggested that treatment with NOB dramatically attenuated lung histopathological changes, wet-to-dry (W/D) ratio, myeloperoxidase (MPO) activity, the numbers of inflammatory cells, and TNF-α, IL-6, and NO in BALF induced by LPS. Furthermore, NOB also significantly inhibited the expression of iNOS and the phosphorylation of NF-κBp65 and IκBα. In vitro, NOB inhibited NF-κB activation and TNF-α, IL-6 production in LPS-stimulated A549 cells. Taken together, these results indicated that NOB exhibited a protective effect on ALI, and the possible mechanism is involved in inhibiting NF-κB activation, subsequently inhibiting LPS-induced inflammatory response.

Citing Articles

Enhancing Lung Recovery: Inhaled Poly(lactic--glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology.

Zhang H, Kuo W, Tu P, Lee C, Wang H, Huang Y ACS Nano. 2025; 19(8):7634-7649.

PMID: 39965088 PMC: 11887484. DOI: 10.1021/acsnano.3c12532.


Anti-Inflammatory Activity of the Combination of Nobiletin and Docosahexaenoic Acid in Lipopolysaccharide-Stimulated RAW 264.7 Cells: A Potential Synergistic Anti-Inflammatory Effect.

Nishi K, Nakatani Y, Ishida M, Kadota A, Sugahara T Nutrients. 2024; 16(13).

PMID: 38999828 PMC: 11243305. DOI: 10.3390/nu16132080.


NOBILETIN AMELIORATES HEATSTROKE-INDUCED ACUTE LUNG INJURY BY INHIBITING FERROPTOSIS VIA P53/SLC7A11 PATHWAY.

Chen H, Xie W, Peng Z, Liu Y, Li H, Huang W Shock. 2023; 61(1):105-111.

PMID: 37695738 PMC: 11841729. DOI: 10.1097/SHK.0000000000002224.


modulates macrophage polarization and inflammatory response by targeting glutaminases through the NF-κB signaling pathway.

Zhao T, Zhang Z, Li Y, Sun Z, Liu L, Deng X Front Immunol. 2023; 14:1180837.

PMID: 37325614 PMC: 10266586. DOI: 10.3389/fimmu.2023.1180837.


Conventional, Complementary and Alternative Medicines: Mechanistic Insights into Therapeutic Landscape of Chronic Obstructive Pulmonary Disease.

Arezina R, Chen T, Wang D Int J Chron Obstruct Pulmon Dis. 2023; 18:447-457.

PMID: 37038544 PMC: 10082417. DOI: 10.2147/COPD.S393540.


References
1.
Lin N, Sato T, Takayama Y, Mimaki Y, Sashida Y, Yano M . Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol. 2003; 65(12):2065-71. DOI: 10.1016/s0006-2952(03)00203-x. View

2.
Baeuerle P, Henkel T . Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994; 12:141-79. DOI: 10.1146/annurev.iy.12.040194.001041. View

3.
Conti G, Tambalo S, Villetti G, Catinella S, Carnini C, Bassani F . Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology. MAGMA. 2010; 23(2):93-101. DOI: 10.1007/s10334-010-0203-1. View

4.
Surh Y, Chun K, Cha H, Han S, Keum Y, Park K . Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 2001; 480-481:243-68. DOI: 10.1016/s0027-5107(01)00183-x. View

5.
Rubenfeld G, Caldwell E, Peabody E, Weaver J, Martin D, Neff M . Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353(16):1685-93. DOI: 10.1056/NEJMoa050333. View